BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

HRT FINANCIAL LP's Holding History (CIK: 0001475597)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 716,826 Value ($000) $6 Avg Close $7.23 Range $6.00 - $8.17
Q3 2025
Shares 57,906 Value ($000) $0 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 124,620 Value ($000) $1 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 58,069 Value ($000) $0 Avg Close $8.07 Range $6.96 - $9.50
Q3 2024
Shares 20,044 Value ($000) $0 Avg Close $7.60 Range $6.17 - $8.88
Q4 2023
Shares 292,412 Value ($000) $2 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 212,698 Value ($000) $2 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 144,062 Value ($000) $1 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 62,223 Value ($000) $1 Avg Close $9.63 Range $7.82 - $12.08
Q3 2022
Shares 23,803 Value ($000) $299 Avg Close $12.87 Range $10.33 - $15.43
Q3 2021
Shares 126,125 Value ($000) $1,812 Avg Close $15.77 Range $14.00 - $18.48
Q2 2021
Shares 118,550 Value ($000) $1,874 Avg Close $13.59 Range $9.23 - $17.74
Q1 2021
Shares 39,830 Value ($000) $405 Avg Close $10.31 Range $7.27 - $14.24
Q4 2020
Shares 301,682 Value ($000) $2,247 Avg Close $5.16 Range $3.36 - $8.99
Q3 2019
Shares 77,424 Value ($000) $221 Avg Close $3.11 Range $2.49 - $3.98
Q2 2015
Shares 10,973 Value ($000) $163 Avg Close $11.37 Range $8.50 - $16.43